We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the...
PALIZADE Phase 2b clinical trial of zetomipzomib in patients with active lupus nephritis actively enrolling; reiterating guidance of topline data in mid-2026 PORTOLA Phase 2a clinical trial of...
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the...
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Chris Kirk...
Everest Medicines (HKEX 1952.HK) and Kezar Life Sciences, Inc. (Nasdaq: KZR) announced today that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0734 | -8.5150812065 | 0.862 | 0.88 | 0.7701 | 558287 | 0.81257603 | CS |
4 | -0.2314 | -22.6862745098 | 1.02 | 1.04 | 0.7502 | 859486 | 0.8678048 | CS |
12 | -0.0437 | -5.25051063319 | 0.8323 | 1.135 | 0.7502 | 788850 | 0.91303584 | CS |
26 | -0.2082 | -20.8868378812 | 0.9968 | 1.135 | 0.6746 | 698021 | 0.88398247 | CS |
52 | -1.6314 | -67.4132231405 | 2.42 | 3.13 | 0.6746 | 679358 | 1.49223325 | CS |
156 | -4.8914 | -86.1161971831 | 5.68 | 18.55 | 0.6746 | 859892 | 6.97406256 | CS |
260 | -18.3114 | -95.8712041885 | 19.1 | 21.6 | 0.6746 | 624050 | 6.76065192 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions